RecruitingNot ApplicableNCT07127484

Hemoadsorption for Severe Ischemic Stroke

Efficacy and Safety of Hemoadsorption for Severe Ischemic Stroke

Sponsor

First Affiliated Hospital of Wannan Medical College

Enrollment

116 participants

Start Date

Jan 5, 2026

Study Type

INTERVENTIONAL

Conditions

Ischemic Stroke Hemoadsorption

Summary

This is a multicenter, randomized-controlled, open-label, blinded endpoint clinical trial that aims to evaluate the efficacy and safety of hemoadsorption for severe ischemic stroke

Eligibility

Min Age: 18 YearsMax Age: 80 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying a procedure called Hemoadsorption for people with hemoadsorption and ischemic stroke. The study is currently recruiting participants at 1 location. People eligible for this study include aged 18 Years to 80 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

PROCEDUREHemoadsorption

Patients in intervention group will receive standard treatment plus hemoadsorption therapy administered once on days 1, 3, and 5 following enrollment.